Is LBAO or MRK a better dividend investment in 2026?

LBAO currently yields 200.00% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: LBAO offers higher current income.

What is the dividend yield difference between LBAO and MRK?

LBAO has a forward dividend yield of 200.00% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 196.75 percentage points.

Home › Compare › LBAO vs MRK

LBAO vs MRK: Dividend Comparison 2026

LBAO yields 200.00% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 LBAO wins by $119.33M in total portfolio value

INVESTMENT

TIME HORIZON10 years

LBAO

● Live price

200.00%

Share price

$1.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$119.36M

Annual income

$60,176,096.29

Full LBAO calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — LBAO vs MRK

📍 LBAO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	LBAO	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, LBAO + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

LBAO pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LBAO

Annual income on $10K today (after 15% tax)

$17,000.00/yr

After 10yr DRIP, annual income (after tax)

$51,149,681.85/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, LBAO beats the other by $51,148,874.10/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LBAO + MRK for your $10,000?

LBAO: 50%MRK: 50%

100% MRK50/50100% LBAO

Portfolio after 10yr

$59.70M

Annual income

$30,088,523.29/yr

Blended yield

50.40%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

LBAO

No analyst data

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LBAO buys

MRK buys

No recent congressional trades found for LBAO or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricLBAOMRK

Forward yield	200.00% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$119.36M ✓	$30.7K
Annual income after 10y	$60,176,096.29 ✓	$950.29
Total dividends collected	$112.49M ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: LBAO vs MRK ($10,000, DRIP)

Year	LBAO Portfolio	LBAO Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$30,700	$20,000.00	$11,192	$351.54	+$19.5K → LBAO
2	$90,232	$57,383.18	$12,524	$392.70	+$77.7K → LBAO
3	$254,173	$157,624.56	$14,015	$438.65	+$240.2K → LBAO
4	$686,927	$414,961.74	$15,682	$489.96	+$671.2K → LBAO
5	$1,783,118	$1,048,106.39	$17,547	$547.23	+$1.77M → LBAO
6	$4,450,613	$2,542,677.12	$19,632	$611.16	+$4.43M → LBAO
7	$10,693,420	$5,931,263.38	$21,963	$682.53	+$10.67M → LBAO
8	$24,760,608	$13,318,648.86	$24,571	$762.18	+$24.74M → LBAO
9	$55,315,649	$28,821,798.66	$27,486	$851.08	+$55.29M → LBAO
10	$119,363,841	$60,176,096.29	$30,745	$950.29	+$119.33M → LBAO

LBAO vs MRK: Complete Analysis 2026

LBAO — Stock

Luboa Group, Inc., operates as an e-commerce company in China. It operates Ingtona, a platform which offers a range of consumer products sourced from China and internationally, as well as provides services relating to the franchise of its offline adult products store. The company was incorporated in 2013 and is based in Jiaxing, China.

Full LBAO Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this LBAO vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LBAO vs SCHD LBAO vs JEPI LBAO vs O LBAO vs KO LBAO vs MAIN LBAO vs JNJ LBAO vs ABBV LBAO vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.